Advanced search
Publication Cover
Nucleosides, Nucleotides & Nucleic Acids Volume 37, 2018 - Issue 12: PROCEEDINGS OF THE 17TH INTERNATIONAL SYMPOSIUM ON PURINE AND PYRIMIDINE METABOLISM IN MAN
Submit an article Journal homepage
140
Views
3
CrossRef citations to date
0
Altmetric
Miscellany

Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development

K. K. JagarlamudiDepartment of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, VHC, Uppsala, Sweden; ;AroCell AB, Virdings allé 32B, SE-754 50 Uppsala, SwedenCorrespondence[email protected]
,
L. WangDepartment of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, VHC, Uppsala, Sweden;
&
S. ErikssonDepartment of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, VHC, Uppsala, Sweden; ;AroCell AB, Virdings allé 32B, SE-754 50 Uppsala, Sweden
Pages 679-686 | Received 09 Jan 2018, Accepted 11 May 2018, Published online: 06 Dec 2018

References

  • World Health Statistics. Monitoring Health for the SDGs, Sustainable Development Goals, ISBN 978-92-92-4-156548-6, World Health Organization: Geneva, 2017, p. 31.
  • Astashkina, A.; Mann, B.; Grainger, D. W. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity, Pharmacol. Ther. 2012, 134, 82–106.
  • Gronowitz, J. S.; Hagberg, H.; Kallander, C. F.; Simonsson, B. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin’s lymphoma, Br. J. Cancer 1983, 47, 487–495.
  • O’Neill, K. L.; Zhang, F.; Li, H.; Fuja, D. G.; Murray, B. K. Thymidine kinase 1 – a prognostic and diagnostic indicator in ALL and AML patients, Leukemia 2007, 21, 560–563.
  • Wu, C.; Yang, R.; Zhou, J.; Bao, S.; Zou, L.; Zhang, P.; Mao, Y.; Wu, J.; He, Q. Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1, J. Immunol. Methods 2003, 277, 157–169.
  • Zhang, F.; Shao, X.; Li, H.; Robison, J. G.; Murray, B. K.; O'Neill, K. L. A monoclonal antibody specific for human thymidine kinase 1, Hybridoma 2001, 20, 25–34.
  • Hanan, S.; Jagarlamudi, K. K.; Liya, W.; Ellen, H.; Staffan, E. Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humans, BMC Biochem. 2012, 13, 12
  • Kumar, J. K.; Aronsson, A. C.; Pilko, G.; Zupan, M.; Kumer, K.; Fabjan, T.; Osredkar, J.; Eriksson, S. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease, Tumor Biol. 2016, 37, 11937–11945.
  • Hughes, J. P.; Rees, S.; Kalindjian, S. B.; Philpott, K. L. Principles of Early Drug discovery, Br. J. Pharmacol. 2011, 162, 1239–1249.
  • IHortobágyi, G. N. Anthracyclines in the treatment of cancer, Drugs 1997, 54, 1–7.
  • Thorn, C. F.; Oshiro, C.; Marsh, S.; Hernandez-Boussard, T.; McLeod, H.; Klein, T. E.; Altman, R. B. Doxorubicin pathways: pharmacodynamics and adverse effects, Pharmacogenet Genomics 2011, 21, 440–446.
  • Direcks, W. G. E.; Berndsen, S. C.; Proost, N.; Peters, G. J.; Balzarini, J.; Spreeuwenberg, M. D.; Lammertsma, A. A.; Molthoff, C. F. M. [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study, Br. J. Cancer. 2008, 99, 481–487.
  • Chen, Y. L.; Eriksson, S.; Chang, Z. F. Regulation and functional contribution of thymidine kinase 1 in repair of DNA damage, J. Biol. Chem. 2010, 285, 27327–27335.
  • Haveman, J.; Sigmond, J.; van Bree, C.; Franken, N. A.; Koedooder, C.; Peter, G.; J. Time course of enhanced activity of deoxycytidine kinase and thymidine kinase 1 and 2 in cultured human squamous lung carcinoma cells, SW-1573, induced by gamma-irradiation, Oncol. Rep. 2006, 16, 901–905.
  • Sasvári-Székely, M.; Spasokoukotskaja, T.; Szóke, M.; Csapó, Z.; Turi, Á.; Szántó, I.; Eriksson, S.; Staub, M. Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2'-deoxyadenosine (Cladribine) in human lymphocytes, Biochem. Pharmacol. 1998, 56, 1175–1179.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.